Literature DB >> 28585303

Different DRB1*03:01-DQB1*02:01 haplotypes confer different risk for celiac disease.

S Alshiekh1,2, L P Zhao3, Å Lernmark1, D E Geraghty4, Å T Naluai5, D Agardh1.   

Abstract

Celiac disease is associated with the HLA-DR3-DQA1*05:01-DQB1*02:01 and DR4-DQA1*03:01-DQB1*03:02 haplotypes. In addition, there are currently over 40 non-HLA loci associated with celiac disease. This study extends previous analyses on different HLA haplotypes in celiac disease using next generation targeted sequencing. Included were 143 patients with celiac disease and 135 non-celiac disease controls investigated at median 9.8 years (1.4-18.3 years). PCR-based amplification of HLA and sequencing with Illumina MiSeq technology were used for extended sequencing of the HLA class II haplotypes HLA-DRB1, DRB3, DRB4, DRB5, DQA1 and DQB1, respectively. Odds ratios were computed marginally for every allele and haplotype as the ratio of allelic frequency in patients and controls as ratio of exposure rates (RR), when comparing a null reference with equal exposure rates in cases and controls. Among the extended HLA haplotypes, the strongest risk haplotype for celiac disease was shown for DRB3*01:01:02 in linkage with DQA1*05:01-DQB1*02:01 (RR = 6.34; P-value < .0001). In a subpopulation analysis, DRB3*01:01:02-DQA1*05:01-DQB1*02:01 remained the most significant in patients with Scandinavian ethnicity (RR = 4.63; P < .0001) whereas DRB1*07:01:01-DRB4*01:03:01-DQA1*02:01-DQB1*02:02:01 presented the highest risk of celiac disease among non-Scandinavians (RR = 7.94; P = .011). The data also revealed 2 distinct celiac disease risk DR3-DQA1*05:01-DQB*02:01 haplotypes distinguished by either the DRB3*01:01:02 or DRB3*02:02:01 alleles, indicating that different DRB1*03:01-DQB1*02:01 haplotypes confer different risk for celiac disease. The associated risk of celiac disease for DR3-DRB3*01:01:02-DQA1*05:01-DQB1*02:01 is predominant among patients of Scandinavian ethnicity.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990HLAzzm321990; celiac disease; genetic risk; massively parallel sequencing; next generation sequencing

Mesh:

Substances:

Year:  2017        PMID: 28585303     DOI: 10.1111/tan.13065

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  7 in total

1.  Celiac disease in pediatric patients according to HLA genetic risk classes: a retrospective observational study.

Authors:  Carlo Tolone; Marisa Piccirillo; Pasquale Dolce; Salvatore Alfiero; Mattia Arenella; Marina Sarnataro; Patrizia Iardino; Alessia Pucciarelli; Caterina Strisciuglio
Journal:  Ital J Pediatr       Date:  2021-05-05       Impact factor: 2.638

Review 2.  Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies.

Authors:  Jason A Tye-Din; Heather J Galipeau; Daniel Agardh
Journal:  Front Pediatr       Date:  2018-11-21       Impact factor: 3.418

Review 3.  Dermatitis Herpetiformis: Novel Perspectives.

Authors:  Emiliano Antiga; Roberto Maglie; Lavinia Quintarelli; Alice Verdelli; Diletta Bonciani; Veronica Bonciolini; Marzia Caproni
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

4.  Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.

Authors:  Wei-Yu Lin; Sarah E Fordham; Eric Hungate; Nicola J Sunter; Claire Elstob; Yaobo Xu; Catherine Park; Anne Quante; Konstantin Strauch; Christian Gieger; Andrew Skol; Thahira Rahman; Lara Sucheston-Campbell; Junke Wang; Theresa Hahn; Alyssa I Clay-Gilmour; Gail L Jones; Helen J Marr; Graham H Jackson; Tobias Menne; Mathew Collin; Adam Ivey; Robert K Hills; Alan K Burnett; Nigel H Russell; Jude Fitzgibbon; Richard A Larson; Michelle M Le Beau; Wendy Stock; Olaf Heidenreich; Abrar Alharbi; David J Allsup; Richard S Houlston; Jean Norden; Anne M Dickinson; Elisabeth Douglas; Clare Lendrem; Ann K Daly; Louise Palm; Kim Piechocki; Sally Jeffries; Martin Bornhäuser; Christoph Röllig; Heidi Altmann; Leo Ruhnke; Desiree Kunadt; Lisa Wagenführ; Heather J Cordell; Rebecca Darlay; Mette K Andersen; Maria C Fontana; Giovanni Martinelli; Giovanni Marconi; Miguel A Sanz; José Cervera; Inés Gómez-Seguí; Thomas Cluzeau; Chimène Moreilhon; Sophie Raynaud; Heinz Sill; Maria Teresa Voso; Francesco Lo-Coco; Hervé Dombret; Meyling Cheok; Claude Preudhomme; Rosemary E Gale; David Linch; Julia Gaal-Wesinger; Andras Masszi; Daniel Nowak; Wolf-Karsten Hofmann; Amanda Gilkes; Kimmo Porkka; Jelena D Milosevic Feenstra; Robert Kralovics; David Grimwade; Manja Meggendorfer; Torsten Haferlach; Szilvia Krizsán; Csaba Bödör; Friedrich Stölzel; Kenan Onel; James M Allan
Journal:  Nat Commun       Date:  2021-10-29       Impact factor: 14.919

5.  High-resolution HLA class II sequencing of Swedish multiple sclerosis patients.

Authors:  Omar Akel; Lue Ping Zhao; Daniel E Geraghty; Alexander Lind
Journal:  Int J Immunogenet       Date:  2022-08-12       Impact factor: 2.385

Review 6.  Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity.

Authors:  Atul Munish Chander; Hariom Yadav; Shalini Jain; Sanjay Kumar Bhadada; Devinder Kumar Dhawan
Journal:  Front Microbiol       Date:  2018-11-01       Impact factor: 5.640

7.  High-resolution genotyping indicates that children with type 1 diabetes and celiac disease share three HLA class II loci in DRB3, DRB4 and DRB5 genes.

Authors:  Shehab Alshiekh; Marlena Maziarz; Daniel E Geraghty; Helena E Larsson; Daniel Agardh
Journal:  HLA       Date:  2020-11-09       Impact factor: 4.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.